NSE · Healthcare · Drug Manufacturers - Specialty & Generic
EPS came in at 9.09 against a street estimate of 12.65 — a miss of 28.1%.
| Document | Date |
|---|---|
| Annual report FY2026 HESTER BIOSCIENCES LIMITED – FY 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from Operations: INR 2,921.36 Million (FY2025: INR 2,864.66 Million) – gr | 2026-06-18 |
| Q4 FY26 earnings call HESTER BIOSCIENCES LIMITED - FY26 EARNINGS SUMMARY HEADLINE NUMBERS • Q4 FY26 Revenue Growth: Standalone revenue grew 22%; consolidated revenue grew | 2026-05-18 |
| Quarterly results · Q4 FY26 HESTER BIOSCIENCES LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • FY 2025-26 Revenue from Operations: INR 2,921.36 million (Standalone), INR 3,325.9 | 2026-05-15 |
| Q3 FY26 earnings call HESTER BIOSCIENCES LIMITED – Q3 & 9M FY26 SUMMARY HEADLINE NUMBERS • Q3 FY26 Revenue (Standalone): grew 12% year-on-year • Q3 FY26 PAT (Profit After | 2026-02-02 |
| Q2 FY26 earnings call HESTER BIOSCIENCES LIMITED – Q2/H1 FY26 EARNINGS SUMMARY --- HEADLINE NUMBERS • Q2 FY26 Stand-Alone Division Product Sales: INR 64 crores (down 12% | 2025-11-14 |
| Quarterly results · Q2 FY26 HESTER BIOSCIENCES LIMITED – FINANCIAL SUMMARY H1 FY2026 (April-September 2025) --- HEADLINE NUMBERS STANDALONE RESULTS (Six Months Ended 30 Septem | 2025-11-12 |
| Q1 FY26 earnings call HESTER BIOSCIENCES LIMITED - Q1 FY 2025-26 SUMMARY HEADLINE NUMBERS • Stand-alone divisional product sales: INR 63 crores (14% decline YoY) • Stand- | 2025-08-04 |
| Quarterly results · Q1 FY26 HESTER BIOSCIENCES LIMITED - Q1 FY2025-26 RESULTS SUMMARY HEADLINE NUMBERS STANDALONE RESULTS (Quarter ended 30 June 2025) • Revenue from Operations | 2025-08-01 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹11 / share ex-date Jul 14, 2026 | 2026-07-14 |
| Announcement | Date |
|---|---|
| Divestment of equity stake in subsidiary Texas Lifesciences Hester Biosciences Limited has sold its equity stake in Texas Lifesciences Private Limited, a subsidiary company. This is a divestment (selling) of the company's ownership in this subsidiary | 2026-03-11 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Hester Biosciences Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.